10X Genomics (TXG) PT Raised to $21 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Derik de Bruin raised the price target on 10X Genomics (NASDAQ: TXG) to $21.00 (from $18.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
